Pacific Wealth Strategies Group, Inc. Abb Vie Inc. Transaction History

Pacific Wealth Strategies Group, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$137.62 - $174.96 $1.49 Million - $1.89 Million	-10,795 Closed	0 $0
Q4 2021 Jan 24, 2022	BUY	$107.43 - $135.93 $149,649 - $189,350	1,393 Added 14.82%	10,795 $1.46 Million
Q3 2021 Oct 14, 2021	BUY	$106.4 - $120.78 $15,640 - $17,754	147 Added 1.59%	9,402 $1.01 Million
Q2 2021 Jul 22, 2021	BUY	$105.21 - $117.21 $22,514 - $25,082	214 Added 2.37%	9,255 $1.04 Million
Q1 2021 Apr 26, 2021	BUY	$102.3 - $112.62 $317,948 - $350,022	3,108 Added 52.38%	9,041 $978,000
Q4 2020 Jan 13, 2021	BUY	$80.49 - $108.67 $271,412 - $366,435	3,372 Added 131.67%	5,933 $636,000
Q3 2020 Oct 22, 2020	BUY	$85.91 - $100.83 $220,015 - $258,225	2,561 New	2,561 $224,000

3,849

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $324B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Pacific Wealth Strategies Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacific Wealth Strategies Group, Inc. with notifications on news.